More Upgrades Elsewhere, Stifel’s Maggie MacDougall increased her target to $53.25 from $50 with a “buy” rating, while Canaccord Genuity’s Yuri Lynk bumped his target to $51 from $46 also with a “buy” recommendation.
“With the stock trading at 7.8 times 2022 estimated EBITDA vs. compounding comps at 11.9 times and defense comps at 11.1 times, we see considerable upside in the shares from current levels,” said Ms. MacDougall.